Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2016-12-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
拟购买北京嘉事爱格医疗器械有限公司少数股权所涉及的北京嘉事爱格医疗器械有限公司股东全部权益评估项目资产评估报告
Capital/Financing Update Classification · 95% confidence The document is titled as an "资产评估报告" (Asset Valuation Report) related to 嘉事堂药业股份有限公司's planned purchase of minority equity in 北京嘉事爱格医疗器械有限公司. It contains detailed asset valuation, financial data, company background, legal and regulatory references, and valuation methods. The document is a comprehensive asset appraisal report used to support a transaction involving equity purchase. It is not an announcement or a brief summary but a full valuation report with financial and operational details. This type of document is best classified as a Capital/Financing Update (CAP) because it relates to a financing activity (purchase of minority equity) and includes valuation information supporting that transaction. It is not an Annual Report, Audit Report, or other categories. The length and detail confirm it is a full report, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2016-12-30 Chinese
审计报告及财务报表
Regulatory Filings
2016-12-30 Chinese
安徽嘉事谊诚医疗器械贸易有限公司审计报告及财务报表
Regulatory Filings
2016-12-30 Chinese
关于资产支持票据进展情况的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the progress of an asset-backed note issuance by the company. It details the approval of the issuance, the structure of the notes, the use of proceeds, credit ratings, and regulatory acceptance status. The document is relatively short (833 characters) and focuses on providing an update on financing activities rather than presenting full financial statements or detailed financial analysis. It does not contain comprehensive financial data or results but rather an update on capital raising progress. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2016-12-28 Chinese
2016年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, attendance, and voting results of a specific shareholders' meeting (the 2016 second extraordinary general meeting) of a company. It details the legal compliance of the meeting process, the qualifications of attendees, and the voting outcomes. It does not contain financial statements, management discussion, or earnings data. It is not a report of financial results or an announcement of a report publication. The document is focused on the legal opinion about the shareholders' meeting and its resolutions, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3634 characters, which is relatively short but contains detailed voting results and legal opinion on the meeting, not just a brief announcement. Therefore, the best classification is DVA.
2016-12-26 Chinese
关于重大资产重组停牌进展暨延期复牌公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the progress and extension of a trading suspension due to a major asset restructuring. It details the timeline of suspension notices, the reasons for delay in disclosing the restructuring plan, approvals from the board and shareholders, and the expected timeline for future disclosures. The document does not contain financial statements or detailed financial analysis but is focused on regulatory disclosure about the status of a major asset restructuring and trading suspension. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about corporate actions and compliance, not the actual restructuring plan or financial report itself. The document length is 3244 characters, which is relatively short and consistent with an announcement rather than a full report.
2016-12-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.